CRL - Charles River Laboratories International Inc.
Close
197.75
-1.540 -0.779%
Share volume: 635,600
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$199.29
-1.54
-0.77%
View ratios
| Fiscal Date | 2022-06-25 | 2022-09-24 | 2022-12-31 | 2023-04-01 | 2023-07-01 | 2023-09-30 | 2023-12-30 | 2024-03-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-03 | 2022-11-02 | 2023-02-22 | 2023-05-11 | 2023-08-09 | 2023-11-08 | 2024-02-14 | 2024-05-09 | |
| Assets | |||||||||
| Total Assets | 7.529 B | 7.383 B | 7.603 B | 7.699 B | 7.772 B | 7.607 B | 8.195 B | 8.153 B | |
| Current Assets | 1.393 B | 1.415 B | 1.439 B | 1.448 B | 1.505 B | 1.444 B | 1.609 B | 1.668 B | |
| Inventories | 256.765 M | 261.522 M | 255.809 M | 262.584 M | 285.280 M | 292.972 M | 380.259 M | 361.281 M | |
| Other Current Assets | 173.848 M | 179.304 M | 196.921 M | 195.875 M | 218.409 M | 194.869 M | 171.257 M | 192.888 M | |
| Short Term Investments | 173.848 M | 179.304 M | 196.921 M | 195.875 M | 218.409 M | 194.869 M | 171.257 M | 192.888 M | |
| Total Receivables | 755.343 M | 778.499 M | 752.390 M | 788.309 M | 800.646 M | 799.310 M | 780.375 M | 786.980 M | |
| Current Cash | 201.333 M | 194.651 M | 233.912 M | 201.587 M | 200.445 M | 157.174 M | 276.771 M | 327.039 M | |
| Total Non-current Assets | 6.136 B | 5.967 B | 6.164 B | 6.251 B | 6.268 B | 6.163 B | 6.586 B | 6.485 B | |
| Property Plant Equipment | 1.383 B | 1.381 B | 1.466 B | 1.494 B | 1.530 B | 1.525 B | 1.640 B | 1.619 B | |
| Other Assets | 113.358 M | 98.558 M | 113.752 M | 153.990 M | 155.465 M | 154.876 M | 268.471 M | 303.147 M | |
| Intangible Assets | 1.032 B | 968.020 M | 955.275 M | 958.119 M | 929.890 M | 886.286 M | 864.051 M | 827.638 M | |
| Goodwill | 2.860 B | 2.776 B | 2.850 B | 2.902 B | 2.917 B | 2.885 B | 3.095 B | 3.070 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 7.529 B | 7.383 B | 7.603 B | 7.699 B | 7.772 B | 7.607 B | 8.195 B | 8.153 B | |
| Total liabilities | 4.882 B | 4.756 B | 4.626 B | 4.591 B | 4.521 B | 4.301 B | 4.598 B | 4.512 B | |
| Total current liabilities | 1.048 B | 1.014 B | 1.092 B | 981.392 M | 1.008 B | 993.816 M | 1.055 B | 954.810 M | |
| Accounts Payable | 211.381 M | 181.629 M | 205.915 M | 120.004 M | 140.204 M | 136.341 M | 168.937 M | 129.682 M | |
| Other liabilities | 195.075 M | 194.710 M | 174.822 M | 186.975 M | 177.252 M | 172.518 M | 223.191 M | 235.441 M | |
| Current long term debt | 2.364 M | 2.079 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 2.997 B | 2.937 B | 2.708 B | 2.744 B | 2.678 B | 2.514 B | 2.647 B | 2.660 B | |
| Other liabilities | 195.075 M | 194.710 M | 174.822 M | 186.975 M | 177.252 M | 172.518 M | 223.191 M | 235.441 M | |
| Minority interest | 45.398 M | 45.091 M | 47.212 M | 48.221 M | 48.299 M | 44.716 M | 62.116 M | 63.490 M | |
| Total Shareholder equity | 2.648 B | 2.627 B | 2.976 B | 3.109 B | 3.252 B | 3.306 B | 3.597 B | 3.640 B | |
| Common stock | 50.823 M | 50.870 M | 50.915 M | 51.097 M | 51.216 M | 51.283 M | 51.312 M | 51.437 M | |
| Retained earnings | 1.183 B | 1.280 B | 1.433 B | 1.536 B | 1.633 B | 1.720 B | 1.887 B | 1.960 B |